1. Home
  2. DALN vs AEON Comparison

DALN vs AEON Comparison

Compare DALN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DALN
  • AEON
  • Stock Information
  • Founded
  • DALN 1954
  • AEON N/A
  • Country
  • DALN United States
  • AEON United States
  • Employees
  • DALN N/A
  • AEON N/A
  • Industry
  • DALN Newspapers/Magazines
  • AEON Biotechnology: Pharmaceutical Preparations
  • Sector
  • DALN Consumer Discretionary
  • AEON Health Care
  • Exchange
  • DALN Nasdaq
  • AEON Nasdaq
  • Market Cap
  • DALN 24.6M
  • AEON 21.6M
  • IPO Year
  • DALN 2008
  • AEON N/A
  • Fundamental
  • Price
  • DALN $6.70
  • AEON $0.12
  • Analyst Decision
  • DALN
  • AEON Strong Buy
  • Analyst Count
  • DALN 0
  • AEON 1
  • Target Price
  • DALN N/A
  • AEON $5.00
  • AVG Volume (30 Days)
  • DALN 52.2K
  • AEON 46.5M
  • Earning Date
  • DALN 03-05-2025
  • AEON 11-13-2024
  • Dividend Yield
  • DALN 2.39%
  • AEON N/A
  • EPS Growth
  • DALN N/A
  • AEON N/A
  • EPS
  • DALN N/A
  • AEON 0.34
  • Revenue
  • DALN $128,286,000.00
  • AEON N/A
  • Revenue This Year
  • DALN N/A
  • AEON N/A
  • Revenue Next Year
  • DALN N/A
  • AEON N/A
  • P/E Ratio
  • DALN N/A
  • AEON $0.35
  • Revenue Growth
  • DALN N/A
  • AEON N/A
  • 52 Week Low
  • DALN $2.98
  • AEON $0.10
  • 52 Week High
  • DALN $7.86
  • AEON $17.17
  • Technical
  • Relative Strength Index (RSI)
  • DALN 49.01
  • AEON 26.21
  • Support Level
  • DALN $6.75
  • AEON $0.10
  • Resistance Level
  • DALN $7.19
  • AEON $0.22
  • Average True Range (ATR)
  • DALN 0.32
  • AEON 0.04
  • MACD
  • DALN -0.13
  • AEON -0.01
  • Stochastic Oscillator
  • DALN 0.00
  • AEON 4.83

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: